glp-1 alzheimer's disease Role of glucagon-like peptide-1 receptor agonists in and Parkinson's disease | Journal of Biomedical Science Role of glucagon-like peptide-1 receptor

The researchers analyzed data from a large, multi-institutional medical records database, including 73,483 adults taking GLP-1sincluding Semaglutide drugs like Ozempic & Wegovy, as well as Victoza (Liraglutide), Trulicity (Dulaglutide), or Byetta (Exenatide)and compared them with the same number of adults not taking the medications, tracking health outcomes for five years after treatment began

: !GLP-1 ,

We spoke to weight loss experts about the benefits of outdoor exercise and why working out is important while taking a GLP-1.

The once-daily pill, approved by the Food and Drug Administration in April, is designed to support weight loss alongside diet and exercise and marks the first new molecular entity cleared under the regulators National Priority Voucher program.The rollout reflects an aggres...

Mary Claire Haver is the Chief AgeWell Officer at Midi Health